riverhead semaglutide & tirzepatide Shows Superior Weight Loss Over in Phase 3 Trial Tirzepatide vs Semaglutide 2026: 22%
Description
JENNIO-IACUC-2023-A066)
Michelle Cardel, PhD, RD, head of global clinical research and nutrition at WeightWatchers
The early trial data is hard to ignore
If you did, you likely saw a lot of warnings about thyroid conditions
Always consult with a registered dietitian or healthcare provider for personalized recommendations
Supplementary Information The online version contains supplementary material available at 10.1007/s11096-023-01694-7
